We have developed a salcaprozate-based ionic liquid (IL) formulation, namely choline salcaprozate (CHONAC), for oral delivery of a glucagon-like peptide-1 (GLP-1) analogue via gastric absorption
The STEP 1 trial published in the New England Journal of Medicine in 2021 showed 14.9% mean weight loss at 68 weeks
When we don't get enough iron, we may experience: Reduced capacity to exercise and skeletal muscle atrophy, even before iron deficiency anemia (IDA) develops Over time, IDA, resulting in abnormal red blood cell formation and symptoms such as fatigue, weakness, difficulty concentrating, impaired cognitive and immune function, and poor body temperature regulation IDA has also been linked to impaired glucose metabolism---potentially due to poor conversion of proinsulin to active insulin in the body
The choice between tirzepatide and semaglutide depends on your health goals, medical history, and preferences